Subscribe

Predicting Cycle One Serious Drug-Related Toxicity (SDRT) in Phase I Oncology Trial

Purpose:

To identify a patient undergoing a Phase I oncology trial at risk for a serious drug-related toxicity (SDRT) based on the study of Hyman et al.

Specialty:

Hematology Oncology

Objective:

dosage calculations, adverse effects, drug levels, overdose and reversal

ICD-10:

T45.1, Y43.3

Evaluation

U/L
mL/min

Results

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

close

RECENT TWEETS

medal descover
medal iphone